GeneFab
PrivateLast Round
Private Equity
Aug 10, 2023
Company Overview
GeneFab is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) providing integrated services for cell and gene therapy design, development, and cGMP manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneFab Comparables
Compare GeneFab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resilience | 80% | |
| ElevateBio | 80% | |
| Ajinomoto Co. Inc | 78% | |
GeneFab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Aug 10, 2023 |
GeneFab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Celadon Partners | Private Equity |
| K5 Global | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 245% MoM, reaching 1.7K.
- Nov 10, 2025
Monthly visitors increased 33% MoM.
GeneFab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GeneFab's valuation, stock price, and market status.